Patient was admitted on (b)(6) 2023.Patient's stage 2 on natal cleft progressed to unstageable on (b)(6) 2023.Evaluation of guardian data was compiled for dates prior to hapi discovery.A total gap in therapy of 143.5 hours was reviewed, which included: 12.5 hours of disconnected enhancer, 92 hour delay in therapy when transferring between units, 34.5 hours of no patient detected/mispositioned enhancer, and 4.5 hours of the pause feature running for the full 30 minutes.There were also 14.5 total days utilizing the device with an incorrect weight selection.
|